Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors

Author(s):
Grimm, S.H.; Gagestein, B.; Keijzer, J.F.; Liu, N.; Wijdeven, R.H.; Lenselink, E.B.; Tuin, A.W.; Nieuwendijk, A.M.C.H. van den; Westen, G.J.P. van; Boeckel, C.A.A. van; Overkleeft, H.S.; Neefjes, J.; Stelt, M. van der
Published
2019
Publication type
Article / Letter to editor
H-89 analogsFms-like tyrosine kinase 3 (FLT3)Acute myeloid leukemia (AML)Inhibitors
Date issued
2019-03-01
Language
English
Is part of
Bioorganic and Medicinal Chemistry (2019), Vol. 27, no. 5, p. 692-699
hdl
1887/120729
doi
10.1016/j.bmc.2019.01.006